Sep 27

PQA 01 - PQA 01: Gastrointestinal Cancer and Central Nervous System

2111 - Gliofocus: A Global, Open-Label, Randomized Phase 3 Study Comparing Niraparib with Temozolomide in Newly Diagnosed MGMT-Unmethylated Glioblastoma

03:00pm - 04:00pm ET

Presenter(s)

William Kennedy, MD - Barrow Neurological Institute, Phoenix, AZ